Showing results (1981-1990 of 2,018) with videos related to
Sort By:
Pageof 202
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2014
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohortLi-Mei Chen, Myron Chang, Yunfeng Dai, et al.JCI Insight|April 23, 2026
Versican regulating viscoelasticity drives pleural fibrosis via mechanotransductive signalingZi-Heng Jia, Xin-Liang He, Xiao-Lin Cui, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|May 12, 2012
[Epidemiological characteristics on the clustering nature of pandemic (H1N1) 2009 in China]Jing-hong Shi, Ni-juan Xiang, Yan-ping Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeuticIñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.The Journal of Infectious Diseases|February 28, 2026
Development and Characterization of Candidate Vaccine Viruses against High Pathogenicity Avian Influenza A(H5) Viruses for Rapid Pandemic ResponseLi Wang, Jieru Wang, Jaber Hossain, et al.Nature Communications|July 22, 2015
A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virusYing Wu, MyungSam Cho, David Shore, et al.Journal of Neurointerventional Surgery|August 24, 2022
COManeci MechANical Dilation for vasospasm (COMMAND): multicenter experienceMohamed M Salem, Jane Khalife, Sohum Desai, et al.International Journal of Antimicrobial Agents|May 29, 2024
Phage therapy combats pan drug-resistant Acinetobacter baumannii infection safely and efficientlyWei-Xiao Wang, Jia-Zhen Wu, Bai-Ling Zhang, et al.Metabolism: Clinical and Experimental|December 27, 2021
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLDLiang-Jie Tang, Hong-Lei Ma, Mohammed Eslam, et al.Cancer Immunology Research|October 12, 2021
Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 AgentsHikmat H Assi, Chihunt Wong, Kimberly A Tipton, et al.Pageof 202